BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/25/2021 2:49:51 AM | Browse: 22 | Download: 22
Publication Name World Journal of Clinical Oncology
Manuscript ID 67608
Country/Territory Spain
Category Oncology
Manuscript Type Minireviews
Article Title Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
Manuscript Source Invited Manuscript
All Author List María Sereno, Oliver Higuera, Patricia Cruz Castellanos, Sandra Falagan, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes and Felipe Couñago
Funding Agency and Grant Number
Corresponding Author María Sereno, MD, PhD, Consultant Physician-Scientist, Medical Oncology Department, Hospital Universitario Infanta Sofía, Paseo Europa 34, ES-28702 Madrid, Spain, San Sebastián de los Reyes 28702, Madrid, Spain. mariasereno75@gmail.com
Key Words Immunotherapy combinations; Anti- programmed cell death protein; Anti-programmed cell death ligand 1; anti-TIGIT; anti-CTLA-4; Combo; Non-small cell lung cancer
Core Tip This review presents the results of the main articles reporting on immunotherapy combinations, with or without chemotherapy, focusing principally on efficacy and toxicity data. The convenience of adding shorter chemotherapy regimens vs the standard 4-cycle regimens to immunotherapy doublets is discussed.
Citation Sereno M, Higuera O, Cruz Castellanos P, Falagan S, Mielgo-Rubio X, Trujillo-Reyes JC, Couñago F. Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer. World J Clin Oncol 2021; In press
2021-04-28 08:20
Peer-Review Started
2021-04-28 08:23
To Make the First Decision
Return for Revision
2021-07-16 05:51
2021-07-28 17:09
Second Decision
2021-11-22 03:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-11-25 02:49
Articles in Press
2021-11-25 02:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Man Liu
Reviewer Code 05402718
Editorial Director
Journal Chief Editor
Company Chief Editor Lian-Sheng Ma
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 67608_Auto_Edited-A.docx
Answering Reviewers 67608-Answering reviewers.pdf
Audio Core Tip 67608-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 67608-Conflict-of-interest statement.pdf
Copyright License Agreement 67608-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 67608-Language certificate.pdf
Peer-review Report 67608-Peer-review(s).pdf
Scientific Misconduct Check 67608-Bing-Liu M-2.png
Scientific Editor Work List 67608-Scientific editor work list.pdf